Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2025-12-24 @ 2:50 PM
NCT ID:
NCT06200259
Eligibility Criteria:
Inclusion Criteria:
* Pathological proven diagnosis of prostatic adenocarcinoma
* History and physical exam to establish clinical staging
* Clinical stage T1-T2c (AJCC 7th edition)
* Prostate specific antigen (PSA) \< 20 ng/mL
* Gleason Score ≤ 7
* Eastern Cooperative Oncology Group (ECOG) Performance status 0-1
* Patients must be 18 years of age or older
* Willingness and ability to complete the International Prostate Symptom Score (IPSS) survey and Expanded Prostate Cancer Index Composite (EPIC) questionnaire
Exclusion Criteria:
* Prior radiotherapy to the pelvic area
* Prior prostate cancer therapy: cryotherapy or hyperthermia
* Prior systemic therapy (chemotherapy) for prostate cancer
* Regional lymph nodes (common iliac, external iliac, internal iliac, presacral) are a target of treatment
* Active diverticulitis, ulcerative colitis, or Crohn's disease
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT06200259
Study Brief:
Protocol Section:
NCT06200259